A1-Receptor Blockade: A Novel Approach for Assessing Myocardial Viability in Chronic Ischemic Cardiomyopathy

Journal of the American Society of Echocardiography

Volumn 16, Issue 7, 2003, Pages 764-769

  Le, D Elizabeth ^b   Pelberg, Robert A ^b   Leong Poi, Howard ^b   Bin, Jian Ping ^b   Linden, Joel ^b   Kaul, Sanjiv ^a  

^a UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR ANTAGONIST; AMINOPHYLLINE; DOBUTAMINE; MICROSPHERE; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; ADENOSINE RECEPTOR; XANTHINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC VALUE; DISEASE MODEL; DOG; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BLOOD FLOW; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE WALL; HEMODYNAMICS; IMAGE ANALYSIS; IMAGING SYSTEM; ISCHEMIC HEART DISEASE; ISOTOPE LABELING; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PROTEIN INDUCTION; RECEPTOR BLOCKING; TECHNIQUE; TRANSTHORACIC ECHOCARDIOGRAPHY; ANIMAL; DRUG ANTAGONISM; HEART MUSCLE ISCHEMIA; PATHOPHYSIOLOGY; PHYSIOLOGY;

AMINOPHYLLINE; ANIMALS; CORONARY STENOSIS; DOGS; MICROSPHERES; MYOCARDIAL ISCHEMIA; RECEPTORS, PURINERGIC P1; XANTHINES;

EID: 0141974322     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0894-7317(03)00214-1     Document Type: Article

References (26)

1. Vanoverchelde JJ, Wijns W, Depre C, Essamri B, Heyndrickx GR, Borgers M, et al. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993;87:1513-23.
2. Gerber BL, Vanoverschelde JJ, Bol A, Michel C, Labar D, Wijns W, et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction: implications for the pathophysiology of chronic myocardial hibernation. Circulation 1996;94:651-9.
3. Chen C, Chen L, Fallon JT, Ma L, Li L, Bow, L, et al. Functional and structural alterations with 24-hour myocardial hibernation and recovery after reperfusion: pig model of myocardial hibernation. Circulation 1996;94:507-16.
4. Sklenar J, Jayaweera AR, Kaul S. A computer-aided approach for the quantification of regional left ventricular function using two-dimensional echocardiography. J Am Soc Echocardiogr 1992;5:33-40.
5. Hood WP, Rackley C, Roller EL. Wall stress in the normal and hypertrophied left ventricle. Am J Cardiol 1968;22:550-8.
6. Heymann MA, Payne BD, Hoffman JI, Rudolph AM. Blood flow measurements with radionuclide labeled particles. Prog Cardiovasc Dis 1977;20:52-79.
7. Firoozan S, Wei K, Linka A, Skyba D, Goodman NC, Kaul S. A canine model of chronic ischemic cardiomyopathy: characterization of regional flow-function relations. Am J Physiol 1999;276:H446-55.
8. Pelberg RA, Spotnitz WD, Bin J-P, Le E, Goodman NC, Kaul S. Mechanism of myocardial dysfunction in the presence of chronic coronary stenosis and normal resting myocardial blood flow: clinical implications. J Am Soc Echocardiogr 2001;14:1047-56.
9. Movsesian MA. Therapeutic potential of cyclic nucleotide phosphodiesterase inhibitors in heart failure. Expert Opin Investig Drugs 2000;9:963-73.
10. Mizumura T, Auchampach JA, Linden J, Bruns RF, Gross GJ. PD 81,723, an allosteric enhancer of the A1 adenosine receptor, lowers the threshold for ischemic preconditioning in dogs. Circ Res 1996;79:415-23.
11. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 2001;41:775-87.
12. Belardinelli L, West A, Crampton RM. Chronotropic and dromotropic actions of adenosine. In: Berne RM, Rall TW, Rubio R, editors. The regulatory function of adenosine. The Hague: Martinus Nijhoff; 1983. p 378-98.
13. Dobson JG Jr. Mechanism if adenosine inhibition of catecholamine-induced responses in the heart. Circ Res 1983;52:151-60.
14. Lorbar M, Skalova K, Nabi A, Chung ES, Meyer TE. Activation of the adenosine A1 receptor attenuates the release of norepinephrine from the presynaptic sympathetic neurons in hypertrophied myocardium. Circulation 1999;100:1730.
15. Ely SW, Berne RM. Protective effects of adenosine in myocardial ischemia. Circulation 1992;85:893-904.
16. Gauthier NS, Headruck JP, Matherne GP. Myocardial function in the working mouse heart overexpressing cardiac A1 adenosine receptors. J Mol Cell Cardiol 1998;30:187-93.
17. 1 receptor mediated protection of the globally ischemic isolated rat heart. J Mol Cell Cardiol 1990;22:39-47.
18. Lasley RD, Mentzer RM. Protective effects of adenosine in the reversibly injured heart. Ann Thorac Surg 1995;60:843-6.
19. Dorheim TA, Wang T, Mentzer RM, Van Wylen DGL. Interstitial purine metabolites during regional myocardial ischemia. J Surg Res 1990;48:491-7.
20. Gidday JM, Hill ME, Rubio R, Berne RM. Estimates of left ventricular interstitial fluid adenosine during catecholamine stimulation. Am J Physiol 1988;254:H207-16.
21. Randhawa MPS, Lasley RD, Mentzer RM. Salutary effects of exogenous adenosine administration on in vivo myocardial stunning. J Thorac Cardiovasc Surg 1996;112:202-4.
22. Pagani FD, Baker LS, Hsi C, Knox M, Fink MP, Visner MS. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. J Clin Invest 1992;90:389-98.
23. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-9.
24. Singh K, Balligand JL, Fischer TA, Smith TW, Kelly RA. Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelia cells: role of extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) and STAT1 alpha. J Biol Chem 1996;271:1111-7.
25. Wheeler MA, Smith SD, Garcia-Cardena G, Nathan CF, Weiss RM, Sessa WC. Bacterial infection induces nitric oxide synthase in human neutrophils. J Clin Invest 1997;99:110-6.
26. Bouma MG, Stad RK, van den Wildenberg FA, Buurman WA. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 1994;153:4159-68.